Removing Quality Roadblocks For Cell & Gene Therapies

Webinar On Demand

Industry experts from Lachman, Regenxbio, Thermo Fisher Scientific (PPD) and Etena Therapeutics discuss key consideration of successful CGT manufacturing and quality strategies.

Key discussions will include:

  • Developing a successful regulatory strategy in the evolving CGT field

  • Achieving CGT quality and compliance through effective quality systems implementation

  • Navigating increasing CGT manufacturing demand and capacity and scalability challenge

  • Avoiding quality and compliance issues to ensure patient access